Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis

University Hospital, Ghent17 enrolled

Overview

Investigation of the influence of giving DHA-rich supplement versus placebo on DHA-status and health evolution of patients with cystic fibrosis

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Giving DHA-rich supplement to patients.

Sex: ALLMin age: 6 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Delta F 508 homozygote * Stable clinical situation Exclusion Criteria: \-

University Hospital Ghent

Ghent, Belgium

Clinical evolution: weight, height, pulmonary function and infection frequency before the study start and during the 2 years of the study

Time frame: before the study start and during the 2 years of the study

Evolution of the fatty acid profile

Time frame: during the 2 years of the study

Oxidative stress status

Time frame: during the 2 years of the study

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.